GE Healthcare, Medtronic receive FDA 510(k) clearance and CE Mark approval on the integration of advanced INVOS™ regional oximetry and Microstream™ capnography technologies on the CARESCAPE precision ...
The INVOS regional oximetry (rSO2) technology solution monitors for signs of hemodynamic changes and deteriorating patient conditions associated with cerebral desaturation events. When used as an ...
TROY, Mich., May 10 /PRNewswire-FirstCall/ -- Somanetics Corporation announced today that its INVOS® System was featured in 24 posters and presentations at the ...
Several methods have been proposed to monitor cerebral perfusion during carotid endarterectomy (CEA), with the purpose of minimizing the risk of perioperative stroke. The INVOS-4100 is able to detect ...
TROY, Mich., April 16 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS - News) announced today a new 510(k) clearance from the U.S. Food and Drug ...
Clinicians now have added ability to personalize care with the integration of two continuous monitoring solutions from Medtronic plc – Microstream™ capnography and INVOS™ regional oximetry technology ...
近年、院外心停止例に対して、神経学的予後を考慮した心肺脳蘇生の考え方が重視されるようになった。実際に、病院到着後速やかに経皮的心肺補助装置（PCPS）などによるPCAIが行われ、それが神経学的予後の改善に結びついている。 こうしたPCAIの導入を ...
UNLABELLED:We compared the percentage haemoglobin oxygenation indices from two near infrared spectrophotometers (NIRS) to determine whether the devices reported similar changes in response to induced ...
循環器救急患者の脳神経学的予後の予測指標として、脳内局所酸素飽和度（rSO2）が有用であり、rSO2が25％以下の症例では予後不良であることが分かった。大阪府済生会千里病院 千里救命救急センター 心血管内治療室の伊藤賀敏氏らが、第58回日本心臓病 ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する